Literature DB >> 24780657

Septic arthritis in the era of immunosuppressive treatments.

O Salar1, B Baker, T Kurien, A Taylor, C Moran.   

Abstract

Immunosuppressants have been the mainstay of treatment for certain inflammatory joint conditions for many years. Developments in this field, namely biological treatments, have led to a change in the classical presentation of acute bone, joint and soft tissue infections. The normal findings of severe pain and tenderness on examination may be absent or simply mimic a typical exacerbation of the chronic joint condition. A minimally raised white cell count and elevated C-reactive protein in the absence of systemic signs of infection may be interpreted as further evidence for the diagnosis of an exacerbation of inflammatory arthritis. We present a unique case of recurrent polyarticular septic arthritis in a patient treated with immunosuppression for refractory rheumatoid arthritis. We hope this article will enable doctors to appreciate and recognise the changing face of septic arthritis in the modern era of immunosuppressant treatments.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24780657      PMCID: PMC4474270          DOI: 10.1308/003588414X13814021678196

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  6 in total

1.  A short story of anti-rheumatic therapy. VIII. The immunodepressants.

Authors:  G Pasero; P Marson
Journal:  Reumatismo       Date:  2012-03-19

Review 2.  Antiinflammatory action of glucocorticoids--new mechanisms for old drugs.

Authors:  Turk Rhen; John A Cidlowski
Journal:  N Engl J Med       Date:  2005-10-20       Impact factor: 91.245

Review 3.  Immunosuppressive drugs: the first 50 years and a glance forward.

Authors:  A C Allison
Journal:  Immunopharmacology       Date:  2000-05

Review 4.  Infections in biological agents used in rheumatic disease.

Authors:  Rachel Byng-Maddick; Michael Ehrenstein
Journal:  Br J Hosp Med (Lond)       Date:  2012-09       Impact factor: 0.825

5.  Treating rheumatoid arthritis to target: recommendations of an international task force.

Authors:  Josef S Smolen; Daniel Aletaha; Johannes W J Bijlsma; Ferdinand C Breedveld; Dimitrios Boumpas; Gerd Burmester; Bernard Combe; Maurizio Cutolo; Maarten de Wit; Maxime Dougados; Paul Emery; Alan Gibofsky; Juan Jesus Gomez-Reino; Boulos Haraoui; Joachim Kalden; Edward C Keystone; Tore K Kvien; Iain McInnes; Emilio Martin-Mola; Carlomaurizio Montecucco; Monika Schoels; Désirée van der Heijde; Desirée van der Heijde
Journal:  Ann Rheum Dis       Date:  2010-03-09       Impact factor: 19.103

6.  Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly.

Authors:  James B Galloway; Kimme L Hyrich; Louise K Mercer; William G Dixon; Bo Fu; Andrew P Ustianowski; Kath D Watson; Mark Lunt; Deborah P M Symmons
Journal:  Rheumatology (Oxford)       Date:  2010-07-31       Impact factor: 7.580

  6 in total
  4 in total

1.  Primary Meningococcal Type C Arthritis: A Case Report and Literature Review.

Authors:  Maximiliano Barahona; Jaime Catalan; Yoshiro Sato; Jaime Hinzpeter
Journal:  Case Rep Orthop       Date:  2017-04-10

Review 2.  Neutrophils: Beneficial and Harmful Cells in Septic Arthritis.

Authors:  Daiane Boff; Helena Crijns; Mauro M Teixeira; Flavio A Amaral; Paul Proost
Journal:  Int J Mol Sci       Date:  2018-02-05       Impact factor: 5.923

3.  Septic Arthritis in Immunosuppressed Patients: Do Laboratory Values Help?

Authors:  Jared Bell; Luke Rasmussen; Arun Kumar; Michael G Heckman; Elizabeth R Lesser; Joseph Whalen; Glenn G Shi; Benjamin K Wilke
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2020-03-17

4.  Synovial Fluid Mediated Aggregation of Clinical Strains of Four Enterobacterial Species.

Authors:  Alicia Macias-Valcayo; Amelia Staats; John-Jairo Aguilera-Correa; Jack Brooks; Tripti Gupta; Devendra Dusane; Paul Stoodley; Jaime Esteban
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.